Ann M Brown

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

D. Wickerham, N. Wolmark, H. Bear, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Greg Yothers, Peter A Kaufman, Norman Wolmark, 2005, The New England journal of medicine.

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

T. Julian, J. Costantino, N. Wolmark, 2007, The Lancet. Oncology.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

T. Julian, J. Costantino, N. Wolmark, 2010, The Lancet. Oncology.

Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

Norman Wolmark, Takamaru Ashikaga, T. Julian, 2010, Journal of surgical oncology.

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.

Greg Yothers, Norman Wolmark, Soonmyung Paik, 2002, Journal of the National Cancer Institute.

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Norman Wolmark, Soonmyung Paik, S. Paik, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.

T. Julian, J. Skelly, N. Wolmark, 2009, Journal of the National Cancer Institute.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

T. Julian, J. Kopec, J. Costantino, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.